Choksi Laboratories announced that USFDA had conducted an inspection at the Company's Contract Test Lab situated at Indore from 2 September 2019 to 6 September 2019.

At the conclusion of the inspection, the US FDA issued a Form 483 with observations.

The Company shall be responding to the USFDA within the stipulated time on these observations. The Company is committed to address these observations promptly.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)